News | April 29, 2014

New LIAISON Ixt/Arrow CellSep Advanced Provides Rapid, Automated Cell Separation For Up To Three Cell Types In A Single Run

DiaSorin CellSep Advanced.jpg

DiaSorin has launched LIAISON Ixt/Arrow CellSep Advanced for the automated isolation of cells directly from whole blood or buffy coat1. Based on proven magnetic bead technology, CellSep Advanced can isolate up to 3 cell types per sample in just 32 minutes per cell type, offering significant time savings compared to manual cell separation methods.

CellSep Advanced is designed for use on the LIAISON Ixt/Arrow instrument for the separation of 1, 2 or 3 cell types in up to 12 samples at a time. Requiring minimal hands-on intervention CellSep Advanced produces good yields of purified cell preparations ready for use in a wide range of downstream applications, including lineage-specific chimerism analysis. The Ixt/Arrow automated platform also minimises human error and ensures reproducibility between runs for consistent and reliable downstream analysis.

“Trials have shown that the performance of CellSep Advanced is equivalent to manual cell separation methods, in terms of cell quality and quantity2,” comments Paul Eros, Global Vice President Molecular, DiaSorin. “CellSep Advanced is part of a growing range of cell separation and nucleic acid extraction kits available for use on the LIAISON Ixt/Arrow instrument, meeting the demands of modern cell analysis applications and ensuring that reliable results are reaching clinicians at the earliest opportunity.”

The LIAISON Ixt/Arrow instrument can also be used for DNA extraction using the Ixt/Arrow Blood DNA extraction kit, ensuring streamlined processing of samples and, by reducing instrumentation requirements, saving valuable bench space in the laboratory.

For more information, visit www.diasorin.com.

About DiaSorin
Headquartered in Italy and listed in the FTSE Italia Mid Cap Index, DiaSorin is a global leader in the In Vitro Diagnostics (IVD) field. For over 40 years the Company has been developing, producing and marketing reagent kits for IVD worldwide. Through constant investments in research and development, and using its own distinctive expertise in the field of immunodiagnostics to deliver a high level of innovation, DiaSorin offers today the broadest range of specialty tests available in the immunodiagnostics market and new tests in the molecular diagnostics markets which identify DiaSorin Group as the IVD “diagnostics specialist”. The molecular division is based in Dublin, Ireland.

References
1. DiaSorin Arrow and LIAISON Ixt CellSep Advanced Instructions for Use (2012/06 version 5) 6.12.02-607-01,EN 09/13. 2. Nagy, M, Henske, B, Anders P, et al (2011) Optimierung und Validierung der Automatischen Zellspearation aus Blut- und Knochenmark-Proben. Poster presented at Deutschen Gesellschaft für Immungenetik, Berlin, 22-24 September 2011. http://www.dgi2011.de/.

SOURCE: DiaSorin

Newsletter Signup
Newsletter Signup